mRNA transcript therapy (Q38264088)

1 September 2017

mRNA transcript therapy (English)

1 reference

1 September 2017

1

Drew Weissman

1 reference

1 September 2017

31 October 2014

1 reference

Expert Review of Vaccines

1 September 2017

1 reference

1 September 2017

14

1 reference

1 September 2017

265-281

1 reference

1 September 2017

2

1 reference

Direct gene transfer into mouse muscle in vivo

1 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Tumor vaccination using messenger RNA: prospects of a future therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

mRNA as a versatile tool for exogenous protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Vaccination with messenger RNA (mRNA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Genome-wide approaches to dissect the roles of RNA binding proteins in translational control: implications for neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Translational control of protein synthesis: the early years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

The protein invasion: a broad review on the origin of the translational system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

The intimate relationships of mRNA decay and translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

5'-Triphosphate RNA is the ligand for RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

21 January 2018

Therapeutic proteins.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Protein therapeutics: a summary and pharmacological classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Efficient cytosolic delivery of molecular beacon conjugates and flow cytometric analysis of target RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Translational control of localized mRNAs: restricting protein synthesis in space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Messenger RNA turnover in eukaryotes: pathways and enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Potential therapeutic applications of RNA cap analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Modification of the 5'-terminus of mRNA by soluble guanylyl and methyl transferases from vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Cationic liposome-mediated RNA transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Novel "anti-reverse" cap analogs with superior translational properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with Poly(A) chains in cis and in trans for a high protein expression level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Synthetic messenger RNA as a tool for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Phosphorothioate cap analogs stabilize mRNA and increase translational efficiency in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Regulation and dysregulation of 3'UTR-mediated translational control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Eukaryotic mRNA decay: methodologies, pathways, and links to other stages of gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

A perspective on mammalian upstream open reading frame function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Translational control by 3'-UTR-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

AU-rich elements: characterization and importance in mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Engineering a direct and inducible protein-RNA interaction to regulate RNA biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

An improved definition of the RNA-binding specificity of SECIS-binding protein 2, an essential component of the selenocysteine incorporation machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Intracellular traffic to compartments for MHC class II peptide loading: signals for endosomal and polarized sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Protein sorting within the MHC class II antigen-processing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

A "silent" polymorphism in the MDR1 gene changes substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Alternative translational products and cryptic T cell epitopes: expecting the unexpected

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Cytolytic CD8+ T cells directed against a cryptic epitope derived from a retroviral alternative reading frame confer disease protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Constitutive display of cryptic translation products by MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

The cap and poly(A) tail function synergistically to regulate mRNA translational efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Nucleic acids and endosomal pattern recognition: how to tell friend from foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Diversity of pathogen sensors in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Spontaneous activation of RNA-sensing pathways in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Processing of double-stranded RNA in mammalian cells: a direct antiviral role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

To sense or not to sense viral RNA--essentials of coronavirus innate immune evasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Extracellular dsRNA: its function and mechanism of cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Parts, assembly and operation of the RIG-I family of motors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Sensing microbial RNA in the cytosol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Innate immune sensing and signaling of cytosolic nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Cytosolic sensing of viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Delivery of immunostimulatory RNA oligonucleotides by gelatin nanoparticles triggers an efficient antitumoral response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Detection of prokaryotic mRNA signifies microbial viability and promotes immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Particle size and activation threshold: a new dimension of danger signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Transcription of RNA templates by T7 RNA polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Preventing nondesired RNA-primed RNA extension catalyzed by T7 RNA polymerase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Self-coded 3'-extension of run-off transcripts produces aberrant products during in vitro transcription with T7 RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Exploiting the mutanome for tumor vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Targeting the tumor mutanome for personalized vaccination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Kunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Nonviral delivery of self-amplifying RNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

A cationic nanoemulsion for the delivery of next-generation RNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Current status of therapy with omalizumab in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Emerging therapies for food allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Omalizumab for treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Prophylactic mRNA vaccination against allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

mRNA vaccination as a safe approach for specific protection from type I allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Antibody-modified T cells: CARs take the front seat for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Transiently redirected T cells for adoptive transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Treatment of advanced leukemia in mice with mRNA engineered T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Genetic engineering of human pluripotent cells using TALE nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

An improved zinc-finger nuclease architecture for highly specific genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

In vivo genome editing using a high-efficiency TALEN system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Knockout rats via embryo microinjection of zinc-finger nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Efficient genome editing in zebrafish using a CRISPR-Cas system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Knockout rats generated by embryo microinjection of TALENs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Generation of targeted mouse mutants by embryo microinjection of TALEN mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Targeted genome editing across species using ZFNs and TALENs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Feeder-free derivation of human induced pluripotent stem cells with messenger RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Human iPSC-based modeling of late-onset disease via progerin-induced aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Steps toward safe cell therapy using induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

HPLC purification of in vitro transcribed long RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Human secretory signal peptide description by hidden Markov model and generation of a strong artificial signal peptide for secreted protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Sorting out the trash: the spatial nature of eukaryotic protein quality control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Erythropoietin gene therapy leads to autoimmune anemia in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Antibodies against erythropoietin and other protein-based therapeutics: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

Autoimmune epitopes in messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2015.973859

10.1586/14760584.2015.973859

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25359562